News Formal

Novo Nordisk to discontinue Levemir insulin in U.S. market

  • 📰 SaltWire Network
  • ⏱ Reading Time:
  • 16 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 63%

Malaysia News News

Malaysia Malaysia Latest News,Malaysia Malaysia Headlines

Explore stories from Atlantic Canada.

Celebrating Wild Caraway: Taste of Nova Scotia's Restaurant of the Year | SaltWire - Novo Nordisk said on Wednesday it would discontinue its long-acting insulin Levemir in the United States, citing manufacturing constraints, reduced patient access and available alternatives.

The announcement comes eight months after Novo said it would cut U.S. list prices for several of its insulin products next year, including a 65% reduction in the list price of Levemir, in response to mounting political pressure over insulin prices. The announcement followed a similar one by Eli Lilly.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 45. in MY
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Malaysia Malaysia Latest News, Malaysia Malaysia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Novo Nordisk to discontinue Levemir insulin in U.S. marketThe Danish drugmaker said supply disruptions would start in mid-January, followed by discontinuation of the Levemir injection pen in April and of Levemir...
Source: YahooFinanceCA - 🏆 47. / 63 Read more »

Factbox-Corporate America weighs business impact of new weight-loss drugsDrugs in a class known as GLP-1 such as Novo Nordisk's Wegovy and Ozempic as well as Eli Lilly's Mounjaro have been shown to help control blood sugar and...
Source: YahooFinanceCA - 🏆 47. / 63 Read more »